- Supported exchanges /
- F /
- 23J0.F
PROMIS NEUROSCIENCES (23J0 F) stock market data APIs
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
PROMIS NEUROSCIENCES Financial Data Overview
| 0.865 | |
| 0.865 | |
| - | |
| 0.865 | |
| 0.865 | |
| 0.76-2.44 | |
| 28 762 K | |
| 29 886 K | |
| 0 | |
| 0.616 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
PROMIS NEUROSCIENCES Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -11 153 589
- Earnings Per Share -0.5
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get PROMIS NEUROSCIENCES Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get PROMIS NEUROSCIENCES End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
